arrow
J

Johan Lindbäck

uppsala university
H指数:47
被引数:7,768

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of Paclitaxel Coated Devices on Limb Salvage and Target Vessel Revascularisation Rates following Isolated Femoropopliteal or Infrapopliteal Endovascular Revascularisation for Chronic Limb Threatening Ischaemia: Insights from the SWEDEPAD 1 Trial

孤立性股腘动脉或腘下动脉腔内血管重建术治疗慢性肢体威胁性缺血后,紫杉醇涂层装置对肢体挽救和靶血管再血管化率的影响:来自SWEDEPAD 1试验的见解

2026-07-150
OAAI
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial

紫杉醇涂层与未涂层装置用于腹股沟下腔内血管重建治疗间歇性跛患者(SWEDEPAD 2):一项多中心、参与者盲法、基于注册登记的随机对照试验

2025-08-310
PRE
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, randomised controlled trial

紫杉醇涂层与未涂层装置在腹股沟下腔内血管重建治疗慢性肢体威胁性缺血中的应用(SWEDEPAD 1):一项多中心、参与者盲法、基于注册的随机对照试验

2025-08-310
PRE
Adverse drug reactions following SARS-CoV-2 vaccination of 3805 healthcare workers cause substantial sick-leave and are correlated to vaccine regimen, age, sex and serological response

SARS-CoV-2疫苗接种后3805名医疗保健工作者出现的不良药物反应导致大量病假,并与疫苗接种方案、年龄、性别和血清学反应相关。

Vaccine
IF3.5
2025-08-060
OA
Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation

基于生物标志物的房颤患者缺血性卒中预测模型

2025-03-010
PRE
Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation

神经胶质生物标志物在未接受口服抗凝治疗的房颤患者缺血性卒中和其他心血管事件风险评估中的应用

2025-01-210
PRE
Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial

重复测量新型心房生物标志物BMP10 (骨形态发生蛋白10) 可改善房颤抗凝患者的风险分层: 来自ARISTOTLE试验的见解

2024-04-022
OAAI